Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 7:23 pm Purchase | 2023-12-31 | 13G | ANNEXON INC ANNX | Logos Global Management LP | 6,944,444 8.300% | 3,844,444 (+124.01%) | Filing History |
| 2024-01-22 4:57 pm Purchase | 2024-01-10 | 13G | ELEVATION ONCOLOGY INC ELEV | Logos Global Management LP | 3,650,000 8.600% | 3,650,000 (New Position) | Filing History |
| 2024-01-22 4:27 pm Purchase | 2023-06-26 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Logos Global Management LP | 3,469,927 9.900% | 3,215,927 (+1266.11%) | Filing History |
| 2024-01-02 12:21 pm Purchase | 2023-12-19 | 13G | ATYR PHARMA INC ATYR | Logos Global Management LP | 5,800,000 9.900% | 5,800,000 (New Position) | Filing History |
| 2023-11-27 5:39 pm Purchase | 2023-09-12 | 13D | OLEMA PHARMACEUTICALS INC OLMA | Logos Global Management LP | 4,266,948 7.800% | 508,130 (+13.52%) | Filing History |
| 2023-07-18 4:01 pm Purchase | 2023-07-06 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Logos Global Management LP | 254,000 8.100% | 254,000 (New Position) | Filing History |
| 2023-06-22 1:25 pm Purchase | 2023-06-13 | 13G | ANNEXON INC ANNX | Logos Global Management LP | 3,100,000 5.800% | 3,100,000 (New Position) | Filing History |
| 2023-02-14 4:23 pm Sale | 2022-12-31 | 13G | ALLAKOS INC ALLK | Logos Global Management LP | 5,286,666 6.200% | -650,000 (-10.95%) | Filing History |
| 2023-02-14 4:14 pm Purchase | 2022-12-31 | 13G | IDEAYA BIOSCIENCES INC IDYA | Logos Global Management LP | 3,900,000 8.100% | 1,250,000 (+47.17%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 1,435,000 4.800% | -115,000 (-7.42%) | Filing History |
| 2023-02-14 3:53 pm Sale | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 2,150,000 4.100% | -804,392 (-27.23%) | Filing History |
| 2022-09-28 5:30 pm Purchase | 2022-09-19 | 13G | ALLAKOS INC ALLK | Logos Global Management LP | 5,936,666 7.000% | 5,936,666 (New Position) | Filing History |
| 2022-05-02 4:02 pm Purchase | 2022-04-20 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 1,550,000 5.200% | 680,000 (+78.16%) | Filing History |
| 2022-03-31 4:23 pm Purchase | 2022-03-21 | 13D | DESIGN THERAPEUTICS INC DSGN | Logos Global Management LP | 2,812,501 5.000% | 2,812,501 (New Position) | Filing History |
| 2022-03-18 5:04 pm Purchase | 2022-03-08 | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 265,000 6.900% | 115,000 (+76.67%) | Filing History |
| 2022-02-15 08:37 am Sale | 2021-12-31 | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 150,000 4.600% | -33,000 (-18.03%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | ALIGOS THERAPEUTICS INC ALGS | Logos Global Management LP | 0 0.000% | -114,911 (Position Closed) | Filing History |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 2,954,392 5.700% | -940,000 (-24.14%) | Filing History |
| 2022-02-14 3:16 pm Sale | 2021-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 870,000 3.000% | -630,000 (-42.00%) | Filing History |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | Logos Global Management LP | 145,000 3.000% | -105,000 (-42.00%) | Filing History |